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Abstract
Background: Cowpea Mosaic Virus (CPMV) is increasingly being used as a nanoparticle platform for multivalent display of
molecules via chemical bioconjugation to the capsid surface. A growing variety of applications have employed the CPMV
multivalent display technology including nanoblock chemistry, in vivo imaging, and materials science. CPMV nanoparticles
can be inexpensively produced from experimentally infected cowpea plants at high yields and are extremely stable.
Although CPMV has not been shown to replicate in mammalian cells, uptake in mammalian cells does occur in vitro and in
vivo. Thus, inactivation of the virus RNA genome is important for biosafety considerations, however the surface
characteristics and chemical reactivity of the particles must be maintained in order to preserve chemical and structural
functionality.
Methodology/Principal Findings: Short wave (254 nm) UV irradiation was used to crosslink the RNA genome within intact
particles. Lower doses of UV previously reported to inactivate CPMV infectivity inhibited symptoms on inoculated leaves but
did not prohibit systemic virus spread in plants, whereas higher doses caused aggregation of the particles and an increase in
chemical reactivity further indicating broken particles. Intermediate doses of 2.0–2.5 J/cm
2 were shown to maintain particle
structure and chemical reactivity, and cellular binding properties were similar to CPMV-WT.
Conclusions: These studies demonstrate that it is possible to inactivate CPMV infectivity while maintaining particle structure
and function, thus paving the way for further development of CPMV nanoparticles for in vivo applications.
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Introduction
Virus particles have received increasing attention as natural
platforms for molecular display in an extensive variety of
nanotechnology applications (reviewed in [1]). Cowpea mosaic
virus (CPMV), a plant virus, has been developed as a
programmable nanoparticle platform for vaccine development
[2–7], and immunoassay detection [8]. Furthermore, we recently
demonstrated CPMV bioavailability and systemic tissue trafficking
in mouse [9] as well as the use of CPMV as a biosensor agent for in
vivo vascular and tumor imaging and tumor targeting [10,11].
CPMV is a comovirus in the picornavirus superfamily, and
infectsthe cowpeaplantVignaunguiculata.Thecrystalstructure ofthe
CPMV capsid reveals icosahedral symmetry and a 31 nm diameter
particle consisting of 60 copies each of a large (L) and a small (S)
capsid protein [12]. CPMV is stable in a variety of environmental
conditions such as low pH, temperatures up to 60uC, and organic
solvents such as dimethyl sulfoxide [13]. Infection of cowpea plants
typically yields 1 mg of CPMV (approximately 10
14 virus particles)
per gram of infected leaf tissue [7].
The CPMV capsid may be manipulated by modification of
cDNAs encoding the viral genomic RNAs. The positive-sense
bipartite single strand RNA genome consists of RNA-1 (5.9 kb),
which codes for several non-structural proteins including the viral
protease and polymerase, and RNA-2 (3.6 kb), which codes for the
viral L and S capsid proteins and the movement protein [14].
Several sites in the L and S proteins have been shown to be
amenable to the insertion of heterologous sequences by genetic
manipulation of cDNA clones of RNA-2 [7] and have facilitated
the development of CPMV for a variety of applications such as
vaccines [2–4,6,15–17], nanoscale chemical building blocks
[13,18–22], and inorganic-organic nanoparticle hybrids [23,24].
Furthermore, each viral capsid contains 300 addressable lysine
residues [25], which allows for efficient and stable isothiocyanate
and NHS-ester coupling reactions to the amine residue of exposed
lysines. Such reactions are used frequently in ligand conjugation
including fluorescent dyes [9,10,26] and click chemistry [27,28]. A
recent study also employed reactive surface carboxylates on
CPMV for bioconjugation [29].
The use of plant viruses for nanobiotechnology also includes
viruses such as cowpea chlorotic mottle virus (CCMV), potato
virus X, tobacco mosaic virus (TMV), and brome mosaic virus
(BMV). Initial studies have been primarily for vaccine applications,
however TMV, CCMV and BMV in particular have been
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well (reviewed in [1,30]). Thus a growing spectrum of virus capsids
with a diversity of size, shape, and chemical character are
becoming available for material science and nanotechnology.
The use of CPMV for biological applications requires
inactivation of infectivity. CPMV cannot be assembled in vitro,
nor can virus-like particles be efficiently produced in heterologous
systems. Empty particles, also known as top component based on
their migration in sucrose gradients, may be recovered or
artificially generated by high-pH treatment [31]. The pH method
may also be used to reduce infectivity [32], however high pH-
treated particles are susceptible to changes in capsid morphology,
and like most virus-like particles that are devoid of RNA they are
relatively less stable substrates for chemistry [31]. Methods
typically employed for inactivation of virus or bacteriophage
infectivity include chemical treatment (formalin, beta propiolac-
tone, chlorine, hydrogen peroxide, ammonia, and sodium
hypochlorite), exposure to extremes of pH or heat, desiccation,
proteolytic degradation, isotope irradiation or UV irradiation [33].
UV radiation is absorbed by nucleic acids and induces
dimerization of adjacent pyrimidines by cyclobutyl ring formation
or other photoproduct linkages, which damage the nucleic acid
strand and thus inhibit transcription [34]. RNA-protein cross-
linking may also occur.
A previous study indicated that a CPMV-based vaccine that
displayed an epitope from canine parvovirus and had been
inactivated by UV could still induce protective antibody responses
[5]. However, that study did not examine whether the chemical
reactivity characteristics of the exterior or interior capsid surfaces
of UV-treated CPMV were maintained. Such reactivity has been
shown to be favored and required for a variety of nanobiotechnol-
ogy applications for viral nanoparticles in vivo [26,35–37]. The aim
of the present study was to inactivate viral infectivity without
disturbing the structural integrity or the reactivity of the capsid
surface, specifically the exposed and chemically addressable
surface residues. UV light (254 nm) was used to crosslink the
viral RNA, and the dose-dependence of infectivity was measured
by infecting Vigna unguiculata seedlings. The intactness and
chemical functionality of the inactivated virions was then assessed
by size-exclusion chromatography, transmission electron micros-
copy, and the surface reactivity was quantified using N-
hydroxysuccinimidyl ester conjugation of a fluorophore.
Results
CPMV particles exhibit diminished infectivity following
UV irradiation
CPMV particles are not sensitive to many standard methods of
virus inactivation (e.g. hypochlorite or peptidase treatment [9],
and methods that preserve capsid integrity such as formaldehyde
treatment inhibit subsequent chemical bioconjugation. To deter-
mine the dose-response of inactivation by short-wave UV
irradiation, samples of purified CPMV diluted to 2 mg/ml
concentration were irradiated at various doses of 254 nm UV
light as follows: 0 J/cm
2 (control), 0.06 J/cm
2, 0.12 J/cm
2,
0.18 J/cm
2, 0.36 J/cm
2, 0.72 J/cm
2, 1.0 J/cm
2, 2.0 J/cm
2, and
2.5 J/cm
2, (Table 1). Following irradiation, virus samples were
directly inoculated into bruised primary leaves of 9 day old cowpea
plants and were monitored daily thereafter for the appearance of
symptoms on inoculated primary and secondary leaves, as well as
reduced growth in secondary leaves indicating systemic spread of
CPMV. No reduction in symptoms compared to control was
observed for those plants that were inoculated with CPMV
receiving doses of 0.06 J/cm
2, 0.12 J/cm
2 and 0.18 J/cm
2 of UV
irradiation (Table 1). A decrease in the amount of lesions in
primary leaves was observed in virus samples that received 0.36 J/
cm
2 and 0.72 J/cm
2 UV irradiation, but both showed only a
minimal reduction in the number of lesions in secondary leaves
(Figure 1, Table 1). CPMV samples that received 1.0 J/cm
2,
2.0 J/cm
2, and 2.5 J/cm
2 doses showed no lesions in inoculated
leaves (Figure 1, Table 1). However, the sample receiving 1.0 J/
cm
2 produced a small amount of lesions and a decrease in size of
secondary leaves (Figure 1I) whereas the sample receiving 2.0 J/
cm
2 or higher showed no signs of infection in any leaves with the
plants displaying no symptoms (Figure 1D, 1J, Table 1).
Additional experiments performed using a local lesion host for
CPMV, Phaseolis vulgaris var. pinto (pinto bean), a host that permits
CPMV replication in inoculated primary leaves but does not
permit systemic spread of virus, showed similar results (Supporting
information files Text S1 and Figure S1). Thus samples treated
with 2.0 J/cm
2, and 2.5 J/cm
2 doses of UV irradiation were
further investigated for their surface chemical reactivity and are
denoted as CPMV-UV2.0 and CPMV-UV2.5 respectively for the
remainder of the study. Untreated CPMV is denoted CPMV-WT.
Given that it would be appealing to use virus-based therapeutics
and vaccines in an edible form, and also that we previously
demonstrated that CPMV is orally bioavailable when inoculated
into mice as infected leaves [9], attempts were also made to
inactivate virus within infected leaves prior to purification.
Infected leaves showing lesions were irradiated at 7.5 J/ cm
2,
10.0 J/ cm
2, or 20.0 J/ cm
2, and homogenates made from the
leaves were suspended in 1.5 ml 0.1 M phosphate buffer and
inoculated directly onto primary leaves of five cowpea seedlings
per each dosed group. No inhibition of infectivity compared to un-
irradiated leaves was observed (data not shown), suggesting that at
least at these doses absorbance of the UV irradiation by leaf
pigments is sufficient to block the effect of UV on virus infectivity.
Effect of UV irradiation on viral genomic RNA
To confirm the effect of CPMV inactivation, the integrity of the
viral genomic RNA in irradiated samples was investigated. RNA
was isolated from CPMV-UV2.0 and CPMV-WT whole virus
particles by phenol-chloroform extraction and ethanol precipita-
tion, and run on an agarose gel under RNAse-free conditions.
RNA-protein crosslinking was observed. When viral protein was
extracted from CPMV-UV2.0 using phenol-chloroform, RNA
yield was reduced, however some viral RNAs remained that
Table 1. Symptoms in inoculated primary leaves and
secondary leaves following UV irradiation of CPMV.
UV Dose (J/cm
2) Symptoms in 1u leaves Symptoms in 2u leaves
0 (WT control) +
a +
0.06 ++
0.12 ++
0.18 ++
0.36 +/2 +
0.76 +/2 +
1.0 2 +/2
2.0 22
2.5 22
afor all doses, +: more than 5 symptomatic lesions per square cm; +/2: less than
5 lesions per square cm; 2: no lesions.
doi:10.1371/journal.pone.0003315.t001
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quantifying the viral RNA extracted from CPMV-WT and three
independently irradiated sets of CPMV-UV2.0 resulted in an
average 64% lower yield of viral genomic RNA when compared to
non-irradiated samples, suggesting that such RNA-protein cross-
linking had occurred (Figure 2B). Little is known about the
structure of RNAs packaged inside CPMV aside from the fact that
each particle can package a single RNA molecule [38–40], and in
other virus systems RNA-RNA crosslinking has been primarily
reported following UV treatment. It is possible inter- or intra-
RNA crosslinking may also occur.
UV-treated particles remain intact following inactivation
of infectivity
CPMV particlesthat contain wild-type genomic RNAs are highly
stable. Empty particles that lack RNA, while they do exist at about
10% of a wild-type infection, are more difficult to produce in large
quantities [31]. Artificially-generated top component, produced by
high-pH treatment of capsids is relatively unstable, suggesting that
CPMV RNA plays a structural role in maintaining capsid integrity
[31]. To determine if crosslinking the viral RNAs led to damaged
capsid integrity or compromised the particle structure, UV-treated
samples were run on a FPLC size exclusion column. Peaks at
260 nm and 280 nm for the CPMV-UV2.0 (data not shown) sample
produced histograms similar to that of CPMV-WT (Figure 3A),
eluting in the same fraction and with an analogous 260:280 ratio.
This observation was further confirmed by SDS electrophoresis
where the capsid protein subunits of inactivated and non-
inactivated samples were identical (not shown). Likewise, electron
microscopy (not shown)demonstrated that UV-treated particleshad
similar morphology to control samples, and no significant difference
in aggregation or in the relative amounts of broken, empty, or
partially full capsids was observed.
In contrast, CPMV-UV2.5 samples showed increased aggrega-
tion, and displayed a separate peak that eluted earlier than wild type
by size-exclusion chromatography (Figure 3B). These results
suggested that some particle disruption was generated by the
higher-dose UV exposure and that thesebrokenparticles then could
aggregate. The morphology of the total CPMV-UV2.5 fraction was
then compared to CPMV-WT by TEM (Figure 3, panels C and D).
The images showed aggregates and debris in the CPMV-UV2.5
fraction (Figure 3D) that was not observed in CPMV-WT
(Figure 3C). Further fractionation of the CPMV-UV2.5 sample into
8 ml (Panel E) and 10 ml (Panel F) peaks confirmed that the 8 ml
fraction contained the aggregated CPMV particles and the 10 ml
peak contained the single particles with morphology similar to
untreated CPMV-WT. Additional experiments showed that the
yield of single, non-aggregated particles could also be improved via
the use of 0.22 mm filtration of the particles prior to ultracentrifu-
gation, along with the addition of 5 mM EDTA, however this was
not as effective as size-exclusion chromatography (data not shown).
UV-inactivated particles retain surface chemical reactivity
Having demonstrated that capsid integrity was essentially
maintained following UV exposure, we then studied the ability
of CPMV-UV2.5 particles to react with an amine-reactive
fluorescent dye, which conjugates to exposed lysines on each
asymmetric unit of the CPMV capsid. Lysine reactivity on the
particle exterior surface is essential for a variety of techniques used
for CPMV nanoblock chemistry including azide-alkyne [3+2]
cycloaddition [28]. CPMV-UV2.5 samples were incubated with N-
hydroxysuccinimide (NHS)-fluorescein at ratios of 1, 5, 10, 25, 50,
100, and 200 dyes molecules/asymmetric unit, in comparison to
CPMV-WT labeled in the same manner. Following removal of
unconjugated dye, the number of dyes/particle was calculated and
compared with CPMV-WT. CPMV-UV2.5 samples demonstrated
Figure 1. UV-inactivation of CPMV infectivity. Primary leaves (panels A–F) were inoculated with CPMV and the presence of symptoms on these
and secondary leaves (panels G–L) of the plant were monitored. Leaves were inoculated with CPMV that had been treated with the following doses of
UV irradiation: 0 J/cm
2 (positive control; panels A, G), 0.72 J/cm
2 (panels B, H), 1.0 J/cm
2 (panels C, I), 2.0 J/cm
2 (panels D, J), 2.5 J/cm
2 (panels E, K) or
no infection (panels F and L). Insets in panels A and G show representative symptoms at approximately 36 magnification. Results shown are
representative of five independent experiments with similar results.
doi:10.1371/journal.pone.0003315.g001
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particles either untreated (CPMV-WT) or treated with 2.0 J/cm
2 of UV radiation (CPMV-UV2.0), and equal quantities of purified RNA were separated on
an agarose gel matrix. Genomic RNA-1 (5.9 kb) and RNA-2 (3.6 kb) are indicated. M: molecular weight markers. B. RNA was extracted in triplicate from
20 micrograms of CPMV-WT or from three individually UV-inactivated samples of CPMV-UV2.0. Results are reported as total viral RNA isolated from
phenol-chloroform extractions (mean+/2S.D.). Data are representative of two independent experiments.
doi:10.1371/journal.pone.0003315.g002
Figure 3. Effect of UV irradiation on capsid morphology by size-exclusion chromatography and TEM. CPMV-WT (A) and CPMV-UV2.5 (B)
were run on a Sepharose 6 FPLC column. Dotted lines indicate absorbance at 260 nm and solid lines indicate absorbance at 280 nm. Single particles
of CPMV-WT typically elute from the column at approximately 10 ml (panel A). CPMV-UV2.5 contains aggregated particles that elute earlier in a peak
at approximately 8 ml (panel B) as well as intact, non-aggregated particles that elute in a peak at 10 ml. Note the difference in y-axis values reflecting
different amounts of particles run on each column. CPMV-WT (panel C) and CPMV-UV2.5 (panel D–F) samples were analyzed by TEM. CPMV-UV2.5
samples (D) contained more aggregation and debris than CPMV-WT. The CPMV-UV2.5 sample was further separated into the 8 ml peak (panel E) and
10 ml peak (panel F) demonstrating the aggregated and single-particle fraction of the UV-treated CPMV. The scale bar represents 200 nm.
doi:10.1371/journal.pone.0003315.g003
UV-Inactivated Nanoparticles
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particle values approximately two-fold greater than the untreated
samples (Figure 4A).
Because the CPMV-UV2.5 sample contained aggregates as
described above, the reactivity of a pure population of UV-
inactivated, single particles (10 ml fraction from Figure 4B) was
also investigated. The purified CPMV-UV2.5 particles were
labeled with excess amounts of NHS-fluorescein and the labeled
dyes per particle calculated and compared with CPMV-WT
labeled in parallel with the same amounts of dye. The purified
CPMV-UV2.5 samples produced dyes per particle values similar to
CPMV-WT (Figure 4B). SDS-PAGE analysis was used to further
demonstrate the retention of surface reactivity. Fluorescein-labeled
CPMV-UV2.5 (CPMV-UV2.5 -F), CPMV-WT (CPMV-F) and
unlabeled CPMV-WT samples were run on a 12% SDS-PAGE
gel and visualized under UV light. Fluorescence was observed in
both large and small subunits of CPMV-UV2.5 and the bands
appeared identical to the CPMV-F sample (Figure 4D). Protein
staining also showed indistinguishable bands among control and
UV-treated samples (Figure 4C).
UV inactivation does not reduce the efficiency of cell
binding and uptake in vitro
Previous studies indicated that UV irradiation of the picorna-
viruses poliovirus and hepatitis A virus abolishes their binding to
cell surface receptors [41]. For CPMV, studies have demonstrated
that wild-type and fluorophore-labeled CPMVs are endocytosed in
a variety of cell types both in vitro and in vivo [9–11]. In addition
CPMV is known to bind to a 54 kilodalton mammalian surface
protein (CPMV-BP) [42]. Using a Virus Overlay Protein Blot
Assay (VOPBA), binding of CPMV-UV2.0 and CPMV-WT
particles to CPMV-BP from HeLa human epithelial cell plasma
membranes was tested indicating no difference in binding capacity
(Figure 5A). When cowpea chlorotic mottle virus (CCMV), a
similarly structured virus that infects the same plant host, was used
in place of CPMV no binding in the 54 kilodalton region was
observed (Figure 5A) [42]. Triplicate samples of HeLa cells were
also incubated with 10
5 particles of CPMV-WT (green bars) or
CPMV- UV2.0 (red bars) per cell for two hours at 4uC to illustrate
binding or at 37uC to show binding and internalization (Figure 5B).
Heat-disrupted capsids showed little binding and uptake when
incubated with HeLa cells at 37uC (Figure 5B). UV-inactivated
particles are still capable of near wildtype cellular binding and
uptake in vitro. These data further indicate that unlike other
picornaviruses, the CPMV capsid remains stable and intact, and
maintains surface reactivities and cellular binding properties
following UV irradiation.
Discussion
In this study, it was shown that CPMV plant infectivity could be
inactivated using 254 nm UV irradiation, while preserving the
structural integrity and chemical reactivity of the capsid. The viral
genomic RNA was extensively crosslinked following UV treatment.
Doses that resulted in complete inactivation of infectivity caused
some breakdown and aggregation of a portion of the virus
population. Removal of these aggregates was required prior to
chemicallabeling to achieveresultssimilartountreated CPMV-WT.
Other methods thatresultininactivation ofpicornaviruses and other
nonenveloped viruses include sodium hypochlorite, formaldehyde,
and proteinase K. In our study these methods either did not affect
CPMV infectivity, or compromised capsid structure or chemical
reactivity (not shown). Together these results indicate that UV is an
appropriate method to inactivate CPMV, but that conditions that
Figure 4. Surface chemical reactivity of CPMV-UV. CPMV-WT
(squares) and CPMV-UV2.5 (triangles) samples were labeled with varying
amounts of excess NHS-Fluorescein (ratio of dye molecules to
asymmetric unit; x-axis), and following purification the dyes per particle
were calculated (y-axis). Panel A shows labeling of CPMV-UV2.5 samples
prior to FPLC fractionation. Panel B shows labeling of CPMV-UV2.5 where
the 10 ml fraction (as in Figure 4) was first purified by FPLC prior to
labeling. CPMV-F and CPMV-UV-F that had been labeled with NHS-
fluorescein were run on SDS PAGE. Both large and small capsid subunits
remain intact (C) and fluoresced under UV light (D).
doi:10.1371/journal.pone.0003315.g004
UV-Inactivated Nanoparticles
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maintain particle morphology and reactivity to bioconjugation.
Previous studies using CPMV for vaccine applications showed
that immunogenicity of CPMV particles was retained following
exposure to 1.8 J/cm
2 of UV at 1 mg/ml [5]. In that study the
morphology of the particles following UV treatment was reported
to be intact by SDS-PAGE and EM, and the ability of UV-treated
virus to replicate was measured in the reporter host Chenopodium
amaranticolor. However, no studies investigating the capsid chemical
reactivity were conducted. In the present study more UV was
required to demonstrate the absence of symptoms in the primary
host, V. unguiculata, which had to be increased to 2.0 J/cm
2 in
order to prevent systemic spread in plants. Titration of the amount
of infectious virus required to observe symptoms in vivo showed
that an inoculum of 10
8 (1 ng) CPMV particles is required for
observing infection in inoculated V.unguiculata leaves. The
difference in UV dose required for inactivation could be a feature
of differences in UV sources, or differences in the particle
concentration during UV treatment. Indeed our studies found that
at virus concentrations greater than 2 mg/ml it was increasingly
difficult to inactivate infectivity even with the higher doses of UV.
These results suggest that the capsids themselves absorb UV and
protect the viral RNA. Finally, since the vaccine studies were
performed using CPMV chimeras that display heterologous
epitopes and the S protein displaying these epitopes is cleaved
on the capsid surface, it may be that chimeric CPMV particles are
less stable to UV irradiation than CPMV-WT [5]. Thus it is
important to standardize the method of UV inactivation of CPMV
and CPMV chimeras, taking into account the dose, volume, and
concentration of virus when preparing particles for in vivo use.
Surprisingly, although CPMV is known to be highly stable, even
relatively low doses of UV lead to some particle aggregation and
breakage. This is similar to a recent study of picornavirus
inactivation by UV, showing that at doses of approximately
1.25 J/cm
2 poliovirus capsids could not protect the genomic RNA
from subsequent nuclease treatment, and the UV-treated particles
could not attach to cellular receptors [41]. Our study indicates that
further purification of CPMV particles following UV inactivation
is required to ensure that intact particles are being administered in
vivo. Indeed, in samples where aggregated and broken particles are
removed by size-exclusion chromatography, the chemical reactiv-
ity of surface lysines is only slightly higher than untreated particles.
These results also suggest that perhaps internal or inter-subunit
lysine residues, which are normally not exposed in intact particles,
may be exposed following UV treatment as a result of RNA
crosslinking and subtle changes in capsid morphology.
Figure 5. Cell-surface binding and uptake of CPMV-WT and CPMV-UV2.0.A .CPMV-WT and the three CPMV-UV2.0 samples used in figure 2B
were incubated separately with the plasma membrane enriched fraction of HeLa cells and virus binding to an established CPMV binding protein
(CPMV-BP) was visualized through VOPBA. No binding was seen when CCMV was used in place of CPMV. B. CPMV-WT (green bars) and CPMV-UV2.0
(red bars) particles were incubated with HeLa cells for 2 hours at 4uC to measure cellular binding or at 37uC to measure binding and internalization.
Respective disrupted particles were incubated at 37uC as well. Percentage of cells with CPMV signal were detected by flow cytometry are indicated
on the y-axis and data are reported as mean+/2S.D. of triplicate samples.
doi:10.1371/journal.pone.0003315.g005
UV-Inactivated Nanoparticles
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as nanoparticle-based imaging sensors, therapeutics, and vaccines
depends on the ability to effectively standardize the properties of
CPMV preparations. The results presented here indicate that
efficient inactivation of CPMV particles is feasible for in vitro and in
vivo use. Nevertheless it is clear that precise conditions for
inactivation must be determined for maintaining particle structure
and chemical reactivity.
Materials and Methods
Preparation and inactivation of purified cowpea mosaic
virus (CPMV)
Virus was purified from wildtype-infected leaves of Kentucky
cowpea (Vigna unguiculata) plants by a method previously described
[9]. Purified virus particles were resuspended at 2 mg/ml in 0.1 M
phosphate buffer (pH 7.0) containing 5 mM EDTA. Aliquots were
irradiated in a Stratalinker 1800 UV Crosslinker (Stratagene, La
Jolla, CA) equipped with 254 nm UV bulbs (5 at 8 watts each)
delivering 3000 mwatts/cm
2. Samples were placed in 100 cm open
petri dishes 15 cm from the light sources, irradiated in energy mode
at doses of 0.06 J/cm
2,0 . 1 2J / c m
2,0 . 1 8J / c m
2,0 . 3 6J / c m
2,0 . 7 2J /
cm
2,1 . 0 0 J / c m
2,2 . 0 0 J / c m
2,o r2 . 5 0 J / c m
2, and subsequently
stored at 4uC for later use. Disruption of CPMV-UV2.0 and CPMV-
WT particles was completed by incubation at 95uCf o r3 0m i n u t e s .
Infectivity of irradiated CPMV on V. unguiculata or
Phaseolis vulgaris var. pinto seedlings
Individual samples which had received varying doses of UV
were used to infect cowpea seedlings where n=6/sample. The
primary leaves of nine-day-old cowpea plants were bruised with
carborundum and infected with either 2.5 mg inactivated or non-
inactivated control CPMV particles per plant at a concentration of
25 ng/ml in 0.1 M phosphate buffer. Inactivated samples were
later used to infect leaves with 5.0 mg per plant at a concentration
of 50 ng/ml. Infections were monitored for the appearance of
lesions and diminished growth in secondary leaves for 16 days
post-inoculation. For infections on pinto bean seedlings, primary
leaves were inoculated with 100, 10, or 1 ug of CPMV that were
non-irradiated or irradiated at 2.0 J/cm
2. Symptoms were
observed at 1 week post-inoculation and lesions quantitated on
inoculated leaves using an AlphaInnotech imaging system.
FPLC analysis and fractionation of wild-type and UV-
inactivated CPMV
Samples were analyzed by FPLC using an AKTA Explorer
Superose
TM 6 size-exclusion column (Amersham Pharmacia) in
which particles suspended in 0.1 M phosphate buffer (pH 7.0)
were run at a rate of 0.4 ml/min and absorbance was measured at
260 and 280 nm. For preparative size-exclusion FPLC, intact
particles were separated from aggregated and broken CPMV
particles through collection of fractions that coincided with the
10 ml elution peak of untreated CPMV particles. These fractions
were collected, pooled and concentrated by ultracentrifugation at
42,000 rpm in a 50.2Ti rotor for 3 hours. Results presented are
representative of more than 6 independent experiments.
Comparison of chemical addressability of CPMV-WT and
CPMV-UV
CPMV-UV2.5 was purified by FPLC fractionation and then
labeled with N-hydroxysuccinimide (NHS)-Fluorescein, [5-(and 6)-
carboxyfluorescein succinimidyl ester] (Pierce Biotechnology Inc,
Rockport, IL) in parallel with CPMV-WT. 200 mg of virus at a
concentration of 1 mg/ml in 10% DMSO was mixed with various
amounts of excess NHS-Fluorescein relative to viral asymmetric
subunits (60/particle) in the following ratios: 1, 5, 10, 25, 50, 100,
150, and 200. The reaction was carried out in a volume of 200 ml
with gentle agitation for 24 hours at room temperature. Unbound
dye was separated from labeled particles using a 10%–
40%sucrose gradient in an SW41 rotor for 2 hrs at 40,000 rpm
(Beckman). Bands of intact, labeled virus were recovered from the
gradient and concentrated by ultracentrifugation in a Ti50 rotor
for 3 hrs at 42,000 rpm. Samples were resuspended in 0.1 M
phosphate buffer and absorbance measured at 260, 280 and
494 nm using a DU 800 spectrophotometer (Beckman Coulter).
Dyes per particle was calculated with the following equation: dyes/
particle=[(Abs4946dilution) / MFluorescein] / (CPMV concentration
/ CPMV molecular weight); where MFluorescein=74,200 and the
molecular weight of CPMV=5.6610
6 grams/mole.
To visualize labeled CPMV proteins, 6 mg samples of CPMV-
UV2.5 and CPMV-WT were mixed with 5 ml4 6LDS with DTT
sample buffer (NuPAGE, Invitrogen) and run on a NuPAGE 12%
Bis-Tris Gel (Invitrogen). The gel was visualized under UV light in
a FluorChem SP imaging system (Alpha Innotech) to detect the
fluorescence of the labeled samples, followed by protein detection
using Simply Blue Safe Stain (Invitrogen).
Transmission electron microscopy
CPMV-UV2.5 and CPMV-WT samples were analyzed. The
CPMV-UV2.5 samples were further fractionated by Sepharose 6
FPLC and the fractions corresponding to aggregates (8 ml elution
volume) and single particles (10 ml elution volume) were also
visualized separately. Carbon-coated, copper grids were glow
discharged immediately before loading samples. Grids were placed
in 10 ml of virus sample for 1 minute, washed three times in sterile
filtered water, and stained in 10 ml drops of 1% uranyl acetate
three times, allowing the grids to soak in the last drop of stain for
2 min. After drying grids, samples were examined under an
electron microscope (Phillips CM100) at 52K magnification.
Analysis of CPMV genomic RNA following UV treatment
Genomic RNA was isolated from CPMV-UV2.0 and CPMV-WT
particles by standard phenol-chloroform extraction of virus particles
followed by ethanol precipitation under RNAse free conditions. Viral
genomic RNAs were analyzed on a 1% agarose RNAse-free gels
(Apex) under native conditions, and visualized under UV light in a
FluorChem SP imaging system (Alpha Innotech). RNA extractions
were performed in triplicate with mean+/2S.D. reported.
Flow cytometry
Intact and disrupted CPMV-UV2.0 and CPMV-WT particles
were incubated with HeLa human epithelial cells cultured in
Dulbecco’s minimal essential media (DMEM) supplemented with
10% fetal bovine serum (FBS), 1% L-glutamine, and 1%
penicillin/streptomycin. Samples were incubated in parallel at a
concentration of 10
5 viruses per cell for a period of 2 hours at 4uC
or 37uC. Samples were then fixed with 2% paraformaldehyde, and
CPMV identified through fluorescent antibody detection and
analyzed by flow cytometry. Cells were acquired on a LSRII flow
cytometer (10,000 events) and analyzed with FlowJo software
(Treestar, San Carlos, CA) in triplicate. Error bars indicate
mean+/2standard deviation (Microsoft Excel).
VOPBA
HeLa cells were propagated and plasma membranes isolated
and stored in 10 mM Tris/HCl, pH 8.0, 10 mg/mL aprotinin and
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as described previously [42]. 10 mg of plasma membrane protein
isolates were run on 4–12% Bis-Tris 1.0 mm NuPAGE gel
(Invitrogen). Proteins samples were then transferred electropho-
retically to Immobilon-P transfer membranes (Millipore). Transfer
membranes were then blocked overnight with 5% w/v milk
solution diluted in wash buffer consisting of PBS with 0.2% Triton
X-100 (Sigma). Samples were then separately subject to one hour
incubation with 10 mg/mL of CPMV-UV2.0 or CPMV-WT in 1%
milk solution with 5% glycerol, washed 4 times with wash buffer
for 5 minutes each, then subject to one hour incubation with anti-
CPMV polyclonal antibody, washed 4 times with wash buffer for
5 minutes each, then incubated one hour with goat anti-rabbit
IgG-HRP, washed 4 times with wash buffer for 5 minutes each,
visualized with chemiluminescence detection (SuperSignal; Pierce)
and exposed on a single CL-Xpossure film (Pierce). The cowpea
chlorotic mottle virus (CCMV) VOPBA was conducted using the
same method with appropriate primary and secondary antibodies
for CCMV detection. Both purified CCMV and the polyclonal
rabbit anti-CCMV antibody were generous gifts from Mark
Young.
Supporting Information
Figure S1 Infectivity of UV-inactivated CPMV in a local lesion
host Phaseolis vulgaris var. Pinto (pinto bean). For infections on
pinto bean seedlings, primary leaves were inoculated with 100, 10,
or 1 ug of CPMV that were non-irradiated or irradiated at 2.0 J/
cm2. Symptoms were observed at 1 week post-inoculation and
lesions quantitated on inoculated leaves using an AlphaInnotech
imaging system. Primary leaves (panels A–C and E–G) were
inoculated with CPMV and the presence of symptoms were
monitored. Leaves were inoculated with CPMV with the following
doses of UV irradiation: 0 J/cm2 (positive control; panels A–D),
2.0 J/cm2 (panels E–H). Lesions per inoculated leaf were
quantitated in panels D and H. Bars represent mean+/2S.D. of
4 leaves/sample.
Found at: doi:10.1371/journal.pone.0003315.s001 (1.30 MB TIF)
Text S1
Found at: doi:10.1371/journal.pone.0003315.s002 (0.65 MB
DOC)
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